Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas J Spoonmore

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Antimicrobial Agents and Chemotherapy|April 29, 2020
Concurrent Local Delivery of Diflunisal Limits Bone Destruction but Fails To Improve Systemic Vancomycin Efficacy during Staphylococcus aureus OsteomyelitisThomas J Spoonmore, Caleb A Ford, Jacob M Curry, et al.
ACS Applied Materials & Interfaces|January 19, 2018
Poly(glycidol) Coating on Ultrahigh Molecular Weight Polyethylene for Reduced Biofilm GrowthJacob N Lockhart, Thomas J Spoonmore, Michael W McCurdy, et al.
Journal of Orthopaedic Research : Official Publication of the Orthopaedic Research Society|December 10, 2020
Diflunisal-loaded poly(propylene sulfide) nanoparticles decrease S. aureus-mediated bone destruction during osteomyelitisCaleb A Ford, Thomas J Spoonmore, Mukesh K Gupta, et al.
Antimicrobial Agents and Chemotherapy|June 22, 2016
Repurposing the Nonsteroidal Anti-inflammatory Drug Diflunisal as an Osteoprotective, Antivirulence Therapy for Staphylococcus aureus OsteomyelitisAndrew S Hendrix, Thomas J Spoonmore, Aimee D Wilde, et al.
Frontiers in Cellular and Infection Microbiology|October 7, 2022
Loss of <i>Vhl</i> alters trabecular bone loss during <i>S. aureus</i> osteomyelitis in a cell-specific mannerCaleb A Ford, Ian M Hurford, Laura E Fulbright, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Antimicrobial Agents and Chemotherapy|April 29, 2020
Concurrent Local Delivery of Diflunisal Limits Bone Destruction but Fails To Improve Systemic Vancomycin Efficacy during Staphylococcus aureus OsteomyelitisThomas J Spoonmore, Caleb A Ford, Jacob M Curry, et al.
ACS Applied Materials & Interfaces|January 19, 2018
Poly(glycidol) Coating on Ultrahigh Molecular Weight Polyethylene for Reduced Biofilm GrowthJacob N Lockhart, Thomas J Spoonmore, Michael W McCurdy, et al.
Journal of Orthopaedic Research : Official Publication of the Orthopaedic Research Society|December 10, 2020
Diflunisal-loaded poly(propylene sulfide) nanoparticles decrease S. aureus-mediated bone destruction during osteomyelitisCaleb A Ford, Thomas J Spoonmore, Mukesh K Gupta, et al.
Antimicrobial Agents and Chemotherapy|June 22, 2016
Repurposing the Nonsteroidal Anti-inflammatory Drug Diflunisal as an Osteoprotective, Antivirulence Therapy for Staphylococcus aureus OsteomyelitisAndrew S Hendrix, Thomas J Spoonmore, Aimee D Wilde, et al.
Frontiers in Cellular and Infection Microbiology|October 7, 2022
Loss of <i>Vhl</i> alters trabecular bone loss during <i>S. aureus</i> osteomyelitis in a cell-specific mannerCaleb A Ford, Ian M Hurford, Laura E Fulbright, et al.
Pageof 1